| Status | Suspended |
| Process | MTA |
| Referral date | 01 July 2010 |
| Topic area |
|
| Description |
Scoped within Batch 12 |
Provisional Schedule
| Closing date for invited submissions / evidence submission: | TBC |
| 1st appraisal committee meeting: | TBC |
Project Team
| Communications manager: | Shalu Kanal |
| Executive Lead: | Peter Littlejohns |
| Project manager: | Jeremy Powell |
| Technical Lead: | Raisa Sidhu |
Consultees
| Manufacturers/sponsors | Apotex (deferiprone) |
| Swedish Orphan Biovitrum (deferiprone) | |
| Hospira (desferrioxamine) | |
| Novartis Pharmaceuticals (deferasirox, desferrioxamine) | |
| Others | Department of Health |
| NHS Eastern and Coastal Kent Teaching | |
| NHS Northamptonshire | |
| Welsh Assembly Government | |
| Patient/carer groups | Action for Children |
| Action for Sick Children | |
| Afiya Trust | |
| Black Health Agency | |
| Children’s Society | |
| Chinese National Healthy Living Centre | |
| Counsel and Care | |
| Equalities National Council | |
| Genetic Alliance UK | |
| Muslim Council of Britain | |
| Muslim Health Network | |
| National Children’s Bureau | |
| National Parent Partnership Network | |
| Sickle Cell Society | |
| South Asian Health Foundation | |
| Specialised Healthcare Alliance | |
| United Kingdom Thalassaemia Society | |
| WellChild | |
| Professional groups | British Association for Services to the Elderly |
| British Committee for Standards in Haematology | |
| British Geriatric Society | |
| British Society for Haematology | |
| British Society for Human Genetics | |
| NHS Sickle Cell & Thalassaemia Screening Programme | |
| National Pharmacy Association | |
| Royal College of General Practitioners | |
| Royal College of Nursing | |
| Royal College of Paediatrics & Child Health | |
| Royal College of Pathologists | |
| Royal College of Physicians | |
| Royal Pharmaceutical Society | |
| Royal Society of Medicine | |
| UK Forum on Haemoglobin Disorders | |
| United Kingdom Clinical Pharmacy Association | |
| United Kingdom National Screening Committee |
Commentators
| Assessment Group | Liverpool Reviews & Implementation Group, University of Liverpool |
| National Institute for Health Research Health Technology Assessment Programme | |
| Associated Guideline Groups | National Clinical Guidelines Centre |
| Associated Public Health Groups | None |
| Comparator manufacturer(s) | None |
| General | Board of Community Health Councils in Wales |
| British National Formulary | |
| Care Quality Commission | |
| Commissioning Support Appraisals Service | |
| Department of Health,Social Services and Public Safety for Northern Ireland | |
| Medicines and Healthcare products Regulatory Agency | |
| National Association of Primary Care | |
| Public Health Wales NHS Trust | |
| NHS Alliance | |
| NHS Commercial Medicines Unit | |
| NHS Confederation | |
| NHS Quality Improvement Scotland | |
| Scottish Medicines Consortium | |
| Relevant research groups | MRC Clinical Trials Unit |
| National Institute for Health Research | |
| Policy Research Institute on Ageing and Ethnicity | |
| Research Institute for the Care of Older People |
For further information on how we develop guidance, please see our page about NICE technology appraisal guidance